本页面由Tiger Trade Technology Pte. Ltd.提供服务

X4制药

2.91
+0.12004.30%
盘后:2.910.00000.00%19:30 EDT
成交量:54.12万
成交额:157.56万
市值:2.89亿
市盈率:-3.28
高:2.97
开:2.83
低:2.82
收:2.79
52周最高:4.83
52周最低:2.70
股本:9,914.67万
流通股本:6,235.43万
量比:0.77
换手率:0.87%
股息:- -
股息率:- -
每股收益(TTM):-0.8867
每股收益(LYR):-1.8726
净资产收益率:-113.08%
总资产收益率:-28.15%
市净率:1.86
市盈率(LYR):-1.55

数据加载中...

2026/10/08

重要事件披露

Form 8-K - Current report
2026/10/07

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/21

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/09

重要事件披露

Form 8-K - Current report
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/01

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/05/13

SEC问询函

Form CORRESP - Correspondence
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/03/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans